Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29843859 | 0.99 | MAPT (0.33) | MAPTTP53ARIDO1TDO2 | |
| SCHEMBL17006054 | 0.99 | MAPT (0.33) | MAPTTP53ARIDO1TDO2 | |
| Hydrochloric Acid SCHEMBL15612709 | 0.87 | HPGD (0.33) | MAPTALDH1A1 | |
| SCHEMBL18040436 | 0.85 | ALOX5 (0.37) | MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL16390251 | 0.85 | HPGD (0.36) | MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL16177878 | 0.84 | MAPT (0.32) | MAPTTP53 | |
| Hydrochloric Acid SCHEMBL3698492 | 0.84 | ALDH1A1 (0.38) | MAPTALDH1A1 | |
| SCHEMBL20994030 | 0.82 | ADRA1D (0.35) | MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL28414018 | 0.81 | CYP19A1 (0.36) | MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL16390542 | 0.80 | NPC1 (0.36) | MAPTTP53ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421702-B2 | Method for producing fluorine-containing olefin | AGC Inc. (JP) | 2019-09-24 | — | — | US | disclosed |
| US-10358400-B2 | Method for producing olefin containing chlorine and fluorine | AGC Inc. (JP) | 2019-07-23 | — | — | US | disclosed |
| EP-3266758-B1 | PRODUCTION METHOD FOR FLUORINE-CONTAINING OLEFIN COMPOUND | AGC INC (JP) | 2019-06-19 | — | — | EP | disclosed |
| US-10252959-B2 | Method for producing fluorine-containing olefin compound | AGC Inc. (JP) | 2019-04-09 | — | — | US | disclosed |
| US-20180127520-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORPORATION (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180086684-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | ASAHI GLASS COMPANY, LIMITED (JP) | 2018-03-29 | — | — | US | disclosed |
| EP-3266758-A1 | PRODUCTION METHOD FOR FLUORINE-CONTAINING OLEFIN COMPOUND | Asahi Glass Company, Limited (JP) | 2018-01-10 | — | — | EP | disclosed |
| US-20170369402-A1 | PRODUCTION METHOD FOR FLUORINE-CONTAINING OLEFIN COMPOUND | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-12-28 | — | — | US | disclosed |
| US-9850325-B2 | Method for producing ring-opening metathesis polymer hydride, and resin composition | ZEON CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| EP-3257885-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER | Asahi Glass Company, Limited (JP) | 2017-12-20 | — | — | EP | disclosed |
| US-20170101360-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-04-13 | — | — | US | disclosed |
| US-9598335-B2 | Method for producing fluorine-containing olefin | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-03-21 | — | — | US | disclosed |
| EP-3042889-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | Asahi Glass Company, Limited (JP) | 2016-07-13 | — | — | EP | disclosed |
| US-20160176791-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-06-23 | — | — | US | disclosed |
| US-20150051353-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORPORATION (JP) | 2015-02-19 | — | — | US | disclosed |
| EP-2826802-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | Zeon Corporation (JP) | 2015-01-21 | — | — | EP | disclosed |
| US-20140087136-A1 | RESIN COMPOSITION AND SEMICONDUCTOR DEVICE BOARD | ZEON CORPORATION (JP) | 2014-03-27 | — | — | US | disclosed |
| EP-2070964-B9 | PROCESS FOR PRODUCTION OF HYDROGENATED POLYMERS AND HYDROGENATED POLYMERS | KURARAY CO (JP) | 2012-10-31 | — | — | EP | disclosed |
| EP-2070964-B1 | PROCESS FOR PRODUCTION OF HYDROGENATED POLYMERS AND HYDROGENATED POLYMERS | KURARAY CO (JP) | 2012-05-16 | — | — | EP | disclosed |
| EP-2070964-A1 | PROCESS FOR PRODUCTION OF HYDROGENATED POLYMERS AND HYDROGENATED POLYMERS | Kuraray Co., Ltd. (JP) | 2009-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170369402-A1 | PRODUCTION METHOD FOR FLUORINE-CONTAINING OLEFIN COMPOUND | FOS, FOSB, CYP4F11 | MAPT 2100/4885TP53 3240/4885AR 2445/4885 |
| US-20180086684-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | FOS, CYP2F1, CYP4F11 | MAPT 1704/4885TP53 2189/4885AR 1945/4885 |
| US-10421702-B2 | Method for producing fluorine-containing olefin | FOS, CYP2F1, CYP4F11 | MAPT 1704/4885TP53 2189/4885AR 1945/4885 |
| US-10252959-B2 | Method for producing fluorine-containing olefin compound | FOS, FOSB, CYP4F11 | MAPT 2231/4885TP53 2524/4885AR 1810/4885 |
| US-10358400-B2 | Method for producing olefin containing chlorine and fluorine | CYP2F1, CYP4F11, CYP4F2 | MAPT 4306/4885TP53 2685/4885AR 4026/4885 |
| US-20170101360-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | FOS, CYP2F1, CYP4F11 | MAPT 1704/4885TP53 2189/4885AR 1945/4885 |
| US-20160176791-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN | FOS, CYP2F1, CYP4F11 | MAPT 1704/4885TP53 2189/4885AR 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.